EpiPen class action lawsuit against Mylan, Pfizer to continue, judge rules

A class action lawsuit claiming Pfizer and Mylan violated antitrust and racketeering laws while managing the epinephrine auto-injector franchise EpiPen will continue, now that a federal judge has shot down an attempt by the companies to dismiss the case.